A search for modifying variants in the FMRP network by De Wolf, Veerle et al.
	    Page 1 of 1 
	  
	  
 
 
BeMGI 2014 Annual Meeting : Poster presentations 
 
 
The del15q11.2: A search for modifying variants in the FMRP network  
 
Veerle De Wolf, Koen Devriendt, Hilde Peeters 
 
Center for human genetics, KU Leuven, Belgium 
 
 
ABSTRACT 
The del15q11.2 is located in a copy number variable region on chromosome 15, flanked by 
BP1 and BP2, located in segmental duplications and contains four genes NIPA1, NIPA2, 
CYFIP1 and TUBGCP5. This copy number variation (CNV) is associated with a variety of 
neuropsychiatric disorders (including ASD and ID), penetrance is reduced and frequently 
inheritance from a normal parent is observed. The del15q11.2 can thus be seen as a rare 
variant with a moderate to large effect, where the effect is thought to be modified by 
additional genetic and/or environmental factors, indicating an oligogenic mode of inheritance. 
CYFIP1, located in the BP1-BP2 deleted region, is an important binding partner of the Fragile 
X Mental Retardation protein (FMRP) and is involved in two different complexes both 
necessary for correct spine morphology in neurons. We hypothesize that variants of the 
FMRP network contribute to the effect of the del15q11.2. 
 
We performed Sanger sequencing of CYFIP1 in 134 patients with a neurodevelopmental 
phenotype carrying the del15q11.2. Samples were recruited in collaboration with other 
genetic centers (CHRU Lille, UMCG Groningen, GOSH London). In addition, we performed 
exome sequencing, using the HiSeq2000 (Illumina), in 7 families to find single nucleotide 
variants (SNVs) in genes of the FMRP network. Families were recruited where no other 
CNVs were found in the patient except for the susceptibility factor del15q11.2, based on a 
validated clinical CNV protocol.  
 
We will present the results of CYFIP1 resequencing in 134 patients with a 
neurodevelopmental phenotype carrying the del15q11.2. In addition, exome sequencing was 
used to search for SNVs in the FMRP network, restricting the analysis to variants with a high 
likelihood of functional relevance. Therefore, we filtered for additional SNVs in the non-
deleted allele of 15q11.2, CYFIP1 interactor genes, FMRP interactor genes and genes of a 
larger defined FMRP network. In addition, we investigated whether de novo SNVs can be 
found explaining the phenotype of the patient. As a result, we have found 3 missense 
variants in CYFIP1, a few de novo variants and several variants in genes of the FMRP 
network.  
 
In conclusion, exome sequencing applying a family based approach is useful to find rare 
SNVs in del15q11.2 patients, both de novo variants and FMRP network variants. However, 
the combined effect with del15q11.2 remains difficult to prove. Functional validation studies 
will enhance knowledge on these combined effects. 
 
